The ₹1 lakh crore RDI Fund marks a shift from grant-based to financing-based innovation support in India. Discuss its institutional architecture and the challenges in ensuring equitable access for genuine beneficiaries.
New · District CollectorCan you hold the district for 72 hours?Floods, a heatwave, an outbreak, a grievance queue. Take the decisions, see the consequences.Play →In this answer
The Union Cabinet's Research, Development and Innovation (RDI) Scheme commits a ₹1 lakh crore corpus to long-tenure, low or nil-interest financing rather than outright grants [1] — repositioning the State from a funder of research to a de-risker of commercialisation, though equitable access remains unsettled.
The shift: from grants to growth capital
- Traditional ANRF/DST support is grant-based; RDI supplies growth and risk capital to sunrise and strategic sectors — energy security, climate action, quantum, AI, biotechnology [1].
- The first Technology Development Board (TDB) call offers concessional loans, equity or hybrid instruments, up to 50% of project cost, collateral-free, with tenures up to 15 years including moratorium [2].
Institutional architecture
PM-chaired ANRF Governing Board → strategic direction
↓
EGoS (Cabinet Secretary) → sectoral scope | DST → nodal department
↓
Special Purpose Fund (SPF) within ANRF — custodian of corpus
↓
2nd-level fund managers (AIFs / DFIs / NBFCs): TDB, BIRAC
↓
Private firms, start-ups, deep-tech ventures
Two-tier funding structure of the RDI Scheme
- The SPF does not invest directly; it channels capital through second-level fund managers [3].
- Operational windows include TDB's high-risk technology commercialisation call [2] and the ₹2,000 crore BIRAC–RDI Fund for biotechnology, deployable over five years [4].
Challenges in reaching genuine beneficiaries
- Awareness deficit: smaller innovators remain uninformed, prompting countrywide industry outreach meets [5].
- Entry thresholds: 50% matching contribution and TRL-4-and-above eligibility favour capital-rich incumbents over early-stage MSMEs and start-ups [2].
- Intermediation risk: commercially cautious fund managers may prefer proven borrowers to genuinely high-risk deep-tech.
- Repayment burden: debt servicing sits uneasily with long, uncertain deep-tech gestation.
- Regional concentration: metro innovation clusters can crowd out Tier-II and state ecosystems.
Financing instruments can succeed where grants plateaued, but only if selection is transparent and reach is broad. Sustained outreach, simplified applications, a start-up-friendly sub-window and public disclosure of sanctions would ensure the corpus serves innovation rather than incumbency — advancing the sovereign technology development ambition the Scheme was designed for.
Sources
- 1Cabinet Approves Research Development and Innovation (RDI) Scheme to scale up Research, Development and Innovation in Strategic and Sunrise Domains, PIB₹1 lakh crore corpus, low/nil-interest financing, PM-chaired ANRF Governing Board, EGoS, DST as nodal department, strategic sectors
- 2Union Minister Dr. Jitendra Singh launches first RDI Fund call, unveils First TDB Window to Fund High-Risk Technology Commercialisation, PIBconcessional loans/equity/hybrid instruments, 15-year tenure, 50% project cost cap, collateral-free, TRL-4 threshold
- 3ANRF Executive Council approves major decisions regarding operationalization of RDI Fund, PIBSpecial Purpose Fund as custodian; capital routed via second-level fund managers (AIFs, DFIs, NBFCs)
- 4Dr Jitendra Singh Announces First National Call of ₹2,000 Crore BIRAC–RDI Fund Under ₹1 Lakh Crore RDI Initiative to Boost Biotech Sector, PIBBIRAC as second-level fund manager, ₹2,000 crore over five years
- 5Countrywide outreach on the ₹1 lakh crore RDI Fund — Mumbai industry interaction, PIBcountrywide outreach meets to build stakeholder awareness